J. McFarlane

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial

L. Holmberg, J. Oxley, J. Sterne, 2016, Trials.

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

Catherine J. Grey, Susan N Moore, P. Fayers, 2022, Bju International.

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

J. Oxley, J. Sterne, F. Hamdy, 2016, British Journal of Cancer.

Modern Transurethral Resection in the Management of Superficial Bladder Tumours

C. Gallegos, G. Howell, R. Issa, 2011 .

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

T. Peters, P. Fayers, D. Aston, 2019, European urology.